[1]
T. A. Nessel, J. B. Morris, T. Roshak, and B. D. Sofen, “Rapid development of multiple nonmelanoma skin cancers secondary to ruxolitinib: a case report”, Int J Res Dermatol, vol. 7, no. 4, pp. 572–574, Jun. 2021.